can you keep weight off after glp 1 The GLP-1 Exit Strategy A Practical Guide to GLP-1

Daily oral orforglipron (Foundayo): Weekly injectable semaglutide for weight loss (Wegovy) : Average weight loss of 14.9 percent of body weight after about 15 months, compared with 2.4 percent in a placebo group Average weight loss of 21 percent of body weight after about 16 months, compared with 3.1 percent in a placebo group Weekly injectable tirzepatide for weight loss (Zepbound): Secondary Health Benefits Though this entire family of drugs has benefits for metabolic health, not every particular drug has been approved for the same conditions

No performance

The evolving place of incretin-based therapies in type 2 diabetes

References Chavda VP, Ajabiya J, Teli D, Bojarska J, Apostolopoulos V